Close Menu

Celgene

Abbott's PCR instrument will help the biopharma companies identify isocitrate dehydrogenase mutations in patients with acute myeloid leukemia.

COTA, which also received funding from HealthScape Advisors, said it aims to reduce the amount of money wasted on unnecessary medical treatment.

The genomics company is set to acquire LifebankUSA, which was founded by HLI's own co-founder, from Celgene's Cellular Therapeutics subsidiary.

Thermo Fisher Scientific, Illumina, Eli Lilly, Celgene, and Roche/Genentech have committed their expertise and funding to build a lung cancer registry.

The gift will go toward the creation of theBartBarlogieCenterfor Molecular Diagnostics and the Celgene Distinguished Endowed Chair for Molecular Therapeutics.

NEW YORK (GenomeWeb) – Human Longevity today announced an agreement to license, develop, and co-promote Celgene Cellular Therapeutics' placental cell population, PSC-100.

NEW YORK (GenomeWeb) – NanoString Technologies said after the close of the market Tuesday that it will develop a companion diagnostic test for Celgene's Revlimid (lenalidomide), which the firm is developing for diffuse large B-cell lymphoma.

NEW YORK (GenomeWeb News) – The New York Economic Development Corporation said today it has launched an initiative that will inject $100 million into life sciences startup companies located in the city through a mix of money from city government, life sciences companies, and venture capital partn

Agios Pharmaceuticals has administered the agent AG-221 to the first patient enrolled in a Phase I trial investigating the drug as a treatment for advanced blood cancers characterized by the IDH2 gene mutation.

Acceleron Pharma recently presented data on two biomarkers that the company is exploring as part of its strategy to advance personalized drugs for breast and squamous cell head and neck cancer patients.

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.